{"anticipatedPostingDate":"2026-11","denomUnitsSelected":"Participants","description":"OS will be defined as the time from the date of randomization to the date of death, whatever the cause. The follow-up of participants still alive will be censored at the moment of last visit/contact. OS will be reported for all participants with PD-L1-positive tumors in both treatment arms.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 11 years","title":"Overall Survival (OS) for Participants With PD-L1-positive Tumor Expression","type":"SECONDARY"}